1-161306722-T-G

Variant summary

Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM5PP5_Very_Strong

The NM_000530.8(MPZ):​c.434A>C​(p.Tyr145Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000805 in 1,613,976 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y145C) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 29)
Exomes 𝑓: 0.0000041 ( 0 hom. )

Consequence

MPZ
NM_000530.8 missense

Scores

7
12

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:6

Conservation

PhyloP100: 2.74
Variant links:
Genes affected
MPZ (HGNC:7225): (myelin protein zero) This gene is specifically expressed in Schwann cells of the peripheral nervous system and encodes a type I transmembrane glycoprotein that is a major structural protein of the peripheral myelin sheath. The encoded protein contains a large hydrophobic extracellular domain and a smaller basic intracellular domain, which are essential for the formation and stabilization of the multilamellar structure of the compact myelin. Mutations in this gene are associated with autosomal dominant form of Charcot-Marie-Tooth disease type 1 (CMT1B) and other polyneuropathies, such as Dejerine-Sottas syndrome (DSS) and congenital hypomyelinating neuropathy (CHN). A recent study showed that two isoforms are produced from the same mRNA by use of alternative in-frame translation termination codons via a stop codon readthrough mechanism. [provided by RefSeq, Oct 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 12 ACMG points.

PM1
In a hotspot region, there are 6 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 11 uncertain in NM_000530.8
PM5
Other missense variant is known to change same aminoacid residue: Variant chr1-161306722-T-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 430459.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=3, Uncertain_significance=1}.
PP5
Variant 1-161306722-T-G is Pathogenic according to our data. Variant chr1-161306722-T-G is described in ClinVar as [Pathogenic]. Clinvar id is 14191.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-161306722-T-G is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MPZNM_000530.8 linkuse as main transcriptc.434A>C p.Tyr145Ser missense_variant 3/6 ENST00000533357.5
MPZNM_001315491.2 linkuse as main transcriptc.434A>C p.Tyr145Ser missense_variant 3/6
MPZXM_017001321.3 linkuse as main transcriptc.464A>C p.Tyr155Ser missense_variant 3/6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MPZENST00000533357.5 linkuse as main transcriptc.434A>C p.Tyr145Ser missense_variant 3/61 NM_000530.8 P1P25189-1

Frequencies

GnomAD3 genomes
AF:
0.0000460
AC:
7
AN:
152110
Hom.:
0
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000458
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000199
AC:
5
AN:
251494
Hom.:
0
AF XY:
0.0000147
AC XY:
2
AN XY:
135922
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000145
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000410
AC:
6
AN:
1461866
Hom.:
0
Cov.:
34
AF XY:
0.00000413
AC XY:
3
AN XY:
727230
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000134
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000460
AC:
7
AN:
152110
Hom.:
0
Cov.:
29
AF XY:
0.0000807
AC XY:
6
AN XY:
74304
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000458
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000642

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:2
Pathogenic, criteria provided, single submitterclinical testingAthena DiagnosticsAug 05, 2021The frequency of this variant in the general population is consistent with pathogenicity (http://gnomad.broadinstitute.org). This variant associates with disease in multiple families. Assessment of experimental evidence suggests this variant results in abnormal protein function. This variant results in abnormal protein function by causing protein to be retained in the endoplasmic reticulum (ER) rather than being transported to the cell membrane or myelin sheath (PMID 29687021). The variant is located in a region that is considered important for protein function and/or structure. -
Pathogenic, criteria provided, single submitterclinical testingGeneDxNov 17, 2021Published functional studies demonstrate that the variant alters normal MPZ function (Bai et al., 2018); Missense variants in this gene are often considered pathogenic (Stenson et al., 2014); In silico analysis supports that this missense variant does not alter protein structure/function; In-silico analysis is inconclusive as to whether the variant alters gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; Reported in a family with peripheral neuropathy and deafness (Starr et al., 2003); This variant is associated with the following publications: (PMID: 29687021, 30677751, 12805115, 26310628, 20461396, 12845552) -
Dejerine-Sottas disease;C0205713:Roussy-Lévy syndrome;C0270912:Charcot-Marie-Tooth disease type 1B;C1843075:Charcot-Marie-Tooth disease dominant intermediate D;C1843153:Charcot-Marie-Tooth disease type 2J;C3888087:Charcot-Marie-Tooth disease type 2I;C4721436:Charcot-Marie-Tooth disease type 4E Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsOct 31, 2018- -
Charcot-Marie-Tooth disease type 1B Pathogenic:1
Pathogenic, no assertion criteria providedliterature onlyOMIMAug 01, 2003- -
MPZ-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesMar 29, 2023The MPZ c.434A>C variant is predicted to result in the amino acid substitution p.Tyr145Ser. This variant has been reported in multiple individuals with autosomal dominant Charcot-Marie-Tooth disease (Leal et al 2003. PubMed ID: 12845552; Starr et al. 2003. PubMed ID: 12805115; Taniguchi T et al 2020. PubMed ID: 33179255). An in vitro experimental study suggests this variant impacts protein localization leading to increased endoplasmic reticulum retention (Bai et al. 2018. PubMed ID: 29687021). This variant is reported in 0.014% of alleles in individuals of Latino descent in gnomAD and is reported in ClinVar as pathogenic by several outside laboratories (http://gnomad.broadinstitute.org/variant/1-161276512-T-G; https://www.ncbi.nlm.nih.gov/clinvar/variation/14191/). Given the evidence, this variant is interpreted as pathogenic. -
Charcot-Marie-Tooth disease, type I Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 24, 2024This sequence change replaces tyrosine, which is neutral and polar, with serine, which is neutral and polar, at codon 145 of the MPZ protein (p.Tyr145Ser). This variant is present in population databases (rs121913603, gnomAD 0.01%). This missense change has been observed in individual(s) with hereditary peripheral neuropathy and hereditary sensory motor neuropathy with deafness (PMID: 12805115, 12845552). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 14191). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MPZ protein function with a negative predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.41
BayesDel_addAF
Uncertain
0.024
T
BayesDel_noAF
Uncertain
0.050
CADD
Pathogenic
32
DANN
Benign
0.96
DEOGEN2
Benign
0.20
T
Eigen
Benign
-0.16
Eigen_PC
Benign
0.019
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Uncertain
0.87
D
M_CAP
Benign
0.024
T
MetaRNN
Uncertain
0.64
D
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.34
N
MutationTaster
Benign
0.99
A;A;A;A
PrimateAI
Uncertain
0.67
T
PROVEAN
Benign
-1.4
N
REVEL
Benign
0.24
Sift
Benign
0.085
T
Sift4G
Benign
0.39
T
Polyphen
0.40
B
Vest4
0.88
MutPred
0.51
Gain of disorder (P = 0.1);
MVP
0.97
MPC
0.86
ClinPred
0.18
T
GERP RS
4.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.49
gMVP
0.97

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.24
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.24
Position offset: -16

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs121913603; hg19: chr1-161276512; API